Finance

Lists
HN30:FRA
Restart Life Sciences Corp
€0.042
0.00%
(0.00) 1D
Sep 7, 8:01:29 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for HN30...
Open
€0.04
High
€0.04
Low
€0.04
Mkt. cap
4.68M
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.08
52-wk low
€0.03
Open
€0.04
High
€0.04
Low
€0.04
Mkt. cap
4.68M
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.08
52-wk low
€0.03
News stories
From web sources and news partners
About Restart Life Sciences Corp
CEO-
Employees-
Founded2004
HeadquartersVancouver, British Columbia, Canada
SectorBiotechnology
Websiterestartlife.co
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
134.55K
331.16K
Cost of goods sold
-
-
72.62K
200.46K
Cost of revenue
-
-
72.62K
200.46K
Research and development expenses
-
-
5.00K
-3.75K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
167.38K
308.52K
256.02K
426.52K
Operating expense
167.84K
309.00K
372.83K
1.10M
Total operating expenses
167.84K
309.00K
445.44K
1.30M
Operating income
-167.84K
-309.00K
-310.89K
-972.69K
Other non operating income
1.61K
-7.44K
-8.37K
-12.41K
EBT including unusual items
-210.98K
-157.32K
-326.14K
-1.02M
EBT excluding unusual items
-166.23K
-316.44K
-319.59K
-996.55K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-210.98K
-157.32K
-326.14K
-1.02M
Net profit margin
-
-
-242.39%
-307.00%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-540.00
-11.10K
Net interest expenses
-
-
-540.00
-11.10K
Depreciation and amortization charges
-
-
-
-
EBITDA
-167.38K
-308.52K
-309.55K
-971.36K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps